Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alexis Gaskin

Orthopaedic Surgery Auburn, CA Medical Doctor

NPI 1407192206 CMS profile 5706404

11795 Education St Ste 201, Auburn, CA 95602

Open in the dashboard

General payments

$57,652

128 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Alexis Gaskin of Auburn, CA is reported in the CMS Open Payments database as having received $57,652 across 128 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,845 10
2024 General $27,388 35
2023 General $13,285 32
2022 General $2,936 32
2021 General $537 9
2020 General $358 6
2019 General $3,304 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alexis Gaskin
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Alexis Gaskin were reported at $9,845. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Alexis Gaskin Orthopaedic Surgery median Middle half National median
2019 $3,304 $644 $140–$2,844 $163
2020 $358 $312 $75–$1,860 $114
2021 $537 $520 $117–$2,495 $132
2022 $2,936 $598 $128–$2,731 $149
2023 $13,285 $461 $128–$2,264 $160
2024 $27,388 $497 $134–$2,475 $164
2025 $9,845 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medical Device Business Services, Inc. $41,797 67 payments
  2. DePuy Synthes Sales Inc. $7,124 18 payments
  3. Supreme Orthopedic Systems, LLC $3,264 2 payments
  4. DePuy Synthes Products, Inc. $2,080 2 payments
  5. Stryker Corporation $1,346 22 payments
  6. Synthes GmbH $936 1 payment
  7. Total Joint Orthopedics, Inc. $446 4 payments
  8. Zimmer Biomet Holdings, Inc. $266 4 payments
  9. Avanos Medical $203 2 payments
  10. Evolution Surgical, Inc $65 1 payment
  11. Other $124 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $42,278 17 payments
  2. Food and Beverage $6,221 92 payments
  3. Travel and Lodging $5,904 18 payments
  4. Education $3,249 1 payment
Products named General payments · program years 2019–2025
  1. ATTUNE $1,547 10 payments
  2. MAKO Knees, Hips $562 6 payments
  3. Velys Ortho-Hip $371 6 payments
  4. EMPHASYS $348 6 payments
  5. Velys Ortho-Knee $342 4 payments
  6. CORAIL $289 2 payments
  7. TRIATHLON $238 7 payments
  8. PINNACLE $233 3 payments
  9. MAKO Knees, Hips $230 2 payments
  10. EXETER $172 1 payment
  11. Other $1,813 32 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

123

Median for Orthopedic Surgery: 203

Drug cost

$850

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 59 $414
Celecoxib Generic 19 $305
Ondansetron Hcl Generic 19 $78
Metoclopramide Hcl Generic 13 $38
Amoxicillin Generic 13 $15

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 40 billing codes

Paid by Medicare

$169,752

Of which drugs: $1,191

Medicare patients

380

Average age 74

Services billed

8,314

236 women, 144 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 72%
Ischemic heart disease 27%
Diabetes 23%
Osteoporosis 23%
Chronic kidney disease 22%
Depression 22%
Atrial fibrillation 19%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 67 7,360 $765
Injection, methylprednisolone acetate, 80 mg J1040 Office 27 35 $215

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

128 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record